In Japan, clinical trials for medical devices require approval from the Pharmaceuticals and Medical Devices Agency (PMDA), adherence to Good Clinical Practice (GCP) guidelines, ethical review board approval, informed consent from participants, and compliance with the Medical Device and In-Vitro Diagnostic Regulations. Read More
Japan classifies medical devices into four categories based on risk: Class I (low risk), Class II (moderate risk), Class III (high risk), and Class IV (highest risk). The classification determines the regulatory requirements, including pre-market approval, quality management, and post-market surveillance, overseen... Read More
A Japan Medical Device Marketing Authorization Holder (MAH) is responsible for ensuring regulatory compliance, product quality, and safety. They handle product registration, post-market surveillance, adverse event reporting, and communication with regulatory authorities. Additionally, they oversee distribution, maintain records, and ensure that marketing... Read More
The Japan medical device Foreign Manufacturer Registration (FMR) process involves submitting an application to the Pharmaceuticals and Medical Devices Agency (PMDA), providing necessary documentation, and ensuring compliance with Japanese regulations. Once reviewed and approved, the foreign manufacturer receives a registration certificate, allowing... Read More
The Ministry of Health, Labour and Welfare (MHLW) in Japan oversees medical device regulation by establishing safety standards, approving new devices, and monitoring post-market performance. It collaborates with the Pharmaceuticals and Medical Devices Agency (PMDA) to ensure compliance, efficacy, and safety, thereby... Read More
In Japan, handling multiple device submissions involves adhering to PMDA guidelines, ensuring thorough documentation, and maintaining clear communication with regulatory authorities. Utilize a centralized submission system, prioritize based on regulatory timelines, and employ local expertise to navigate cultural and regulatory nuances effectively.... Read More
The responsibility for compiling the Device Master File (DMF) in Japan typically falls to the manufacturer’s regulatory affairs team or the designated legal representative in Japan. These individuals ensure that all required information is accurate, complete, and compliant with PMDA guidelines, coordinating... Read More
To document the design process in a Device Master File (DMF) for Japan, include detailed descriptions of design inputs, outputs, verification and validation activities, risk assessments, design reviews, and changes made during the development process. Ensure all design documentation follows PMDA guidelines... Read More
A Device Master File (DMF) for Japan includes detailed information about the medical device’s design, manufacturing processes, quality control procedures, material specifications, components, test data, stability data, and supplier information. It also covers any proprietary methods or technologies used. This comprehensive documentation... Read More
The Marketing Authorization Holder (MAH) in Japan plays a critical role in document submission by ensuring all regulatory submissions are accurate, complete, and compliant with PMDA requirements. The MAH coordinates with manufacturers, compiles necessary documentation, submits documents through the PMDA’s system, and... Read More